LPL Financial’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
27,324
+6,835
+33% +$371K ﹤0.01% 3719
2025
Q4
$945K Buy
20,489
+1,172
+6% +$52.4K ﹤0.01% 4127
2025
Q3
$696K Buy
19,317
+6,582
+52% +$218K ﹤0.01% 4351
2025
Q2
$414K Buy
12,735
+3,854
+43% +$126K ﹤0.01% 4532
2025
Q1
$335K Buy
8,881
+2,318
+35% +$185K ﹤0.01% 4497
2024
Q4
$537K Sell
6,563
-6,902
-51% -$685K ﹤0.01% 4034
2024
Q3
$1.54M Buy
13,465
+3,947
+41% +$356K ﹤0.01% 2977
2024
Q2
$719K Buy
9,518
+956
+11% +$65.1K ﹤0.01% 3553
2024
Q1
$585K Sell
8,562
-2,202
-20% -$152K ﹤0.01% 3646
2023
Q4
$676K Buy
10,764
+1,139
+12% +$59.2K ﹤0.01% 3404
2023
Q3
$491K Buy
9,625
+1,027
+12% +$50.7K ﹤0.01% 3502
2023
Q2
$429K Buy
+8,598
New +$408K ﹤0.01% 3565

Other funds holding PCVX